A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027)

Clinical trial NCT07734610 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07734610
Sponsor: Merck Sharp & Dohme LLC
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Severe Renal Impairment Healthy

Start date: 2026-08-17
Primary completion: 2027-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.